Navamedic ASA (OSL:NAVA)

Navamedic ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	52.95	74.16	37.29	38.04	55.3	52.62
Cash & Short-Term Investments	52.95	74.16	37.29	38.04	55.3	52.62
Cash Growth	24.13%	98.89%	-1.97%	-31.21%	5.09%	32.93%
Accounts Receivable	54.07	43.3	45.59	38.04	39.46	31.36
Other Receivables	10.51	12.65	10.37	16.83	18.43	22.03
Receivables	64.58	55.94	55.96	54.87	98.51	90.99
Inventory	116.16	116.56	81.89	105.2	79.64	61.88
Prepaid Expenses	-	15.93	8.67	10.62	-	-
Other Current Assets	-	9.3	16.19	1.39	10.09	-0
Total Current Assets	233.69	271.88	200	210.12	243.54	205.49
Property, Plant & Equipment	4.05	6.19	8.74	9.75	7.12	8.31
Long-Term Investments	-	-	-	-	-	18.84
Goodwill	196.91	207.57	159.05	156.73	100.74	61.03
Other Intangible Assets	216.01	250.89	92.56	97.63	30.54	27.34
Long-Term Deferred Tax Assets	0.93	0.93	0.93	0.93	0.84	9.17
Total Assets	656.62	741.75	467.48	507.32	382.77	330.18

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	78.12	90.63	50.27	68.3	65.57	70.53
Accrued Expenses	-	43.1	47.05	42.45	40.07	29.72
Current Portion of Long-Term Debt	31.43	40.69	35.44	51.07	13.62	9.75
Current Portion of Leases	1.43	2.52	2.87	2.45	1.87	1.84
Current Income Taxes Payable	2.88	6.03	5.2	8.15	4.71	10.71
Other Current Liabilities	44.95	4.75	-0	16.86	0.22	13.16
Total Current Liabilities	158.8	187.73	140.82	189.28	126.06	135.71
Long-Term Debt	149.29	165	78.57	95.48	38.37	29.24
Long-Term Leases	0.86	0.01	1.69	3.89	4.86	5.82
Long-Term Deferred Tax Liabilities	6.88	7.75	8.36	9.27	-	-
Other Long-Term Liabilities	34.71	47.18	21.36	3.99	3.76	8.17
Total Liabilities	350.53	407.67	250.8	301.91	173.05	178.94

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	17.75	17.75	13.07	12.84	12.75	12.1
Additional Paid-In Capital	314.46	314.46	198.24	192.58	190.41	165.83
Retained Earnings	-26.12	1.88	5.36	-0.02	6.56	-26.69
Comprehensive Income & Other	0	-	0	-0	-	-
Shareholders' Equity	306.09	334.08	216.67	205.4	209.72	151.24
Total Liabilities & Equity	656.62	741.75	467.48	507.32	382.77	330.18

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	183	208.22	118.57	152.89	58.72	46.64
Net Cash (Debt)	-130.05	-134.07	-81.29	-114.86	-3.42	5.98
Net Cash Growth	-	-	-	-	-	-64.41%
Net Cash Per Share	-5.82	-7.04	-4.65	-6.65	-0.20	0.36
Filing Date Shares Outstanding	24	23.98	17.66	17.35	17.23	16.35
Total Common Shares Outstanding	24	23.98	17.66	17.35	17.23	16.35
Working Capital	74.89	84.16	59.18	20.84	117.48	69.78
Book Value Per Share	12.76	13.93	12.27	11.84	12.17	9.25
Tangible Book Value	-106.84	-124.38	-34.94	-48.95	78.44	62.86
Tangible Book Value Per Share	-4.45	-5.19	-1.98	-2.82	4.55	3.85
Machinery	-	7.87	7.18	5.18	1.18	1.14

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error